{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:16Z","timestamp":1791332536227,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00125-013-2926-9","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T06:44:21Z","timestamp":1368686661000},"page":"1813-1825","source":"Crossref","is-referenced-by-count":95,"title":["Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2\/seipin-deficient mice"],"prefix":"10.1007","volume":"56","author":[{"given":"X.","family":"Prieur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Le May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Takigawa-Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zelenika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lathrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Costet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Magr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"2926_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316893","volume":"19","author":"J Capeau","year":"2010","unstructured":"Capeau J, Magr\u00e9 J, Caron-Debarle M et al (2010) Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr Dev 19:1\u201320","journal-title":"Endocr Dev"},{"key":"2926_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","volume":"28","author":"J Magr\u00e9","year":"2001","unstructured":"Magr\u00e9 J, Del\u00e9pine M, Khallouf E et al (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365\u2013370","journal-title":"Nat Genet"},{"key":"2926_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","volume":"31","author":"AK Agarwal","year":"2002","unstructured":"Agarwal AK, Arioglu E, de Almeida S et al (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31:21\u201323","journal-title":"Nat Genet"},{"key":"2926_CR4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","volume":"93","author":"C Kim","year":"2008","unstructured":"Kim C, Del\u00e9pine M, Boutet E et al (2008) Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93:1129\u20131134","journal-title":"J Clin Endocrinol Metab"},{"key":"2926_CR5","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","volume":"119","author":"YK Hayashi","year":"2009","unstructured":"Hayashi YK, Matsuda C, Ogawa M et al (2009) Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 119:2623\u20132633","journal-title":"J Clin Invest"},{"key":"2926_CR6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","volume":"84","author":"AW Cohen","year":"2004","unstructured":"Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004) Role of caveolae and caveolins in health and disease. Physiol Rev 84:1341\u20131379","journal-title":"Physiol Rev"},{"key":"2926_CR7","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","volume":"104","author":"KM Szymanski","year":"2007","unstructured":"Szymanski KM, Binns D, Bartz R et al (2007) The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci USA 104:20890\u201320895","journal-title":"Proc Natl Acad Sci USA"},{"key":"2926_CR8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1194\/jlr.R023754","volume":"53","author":"BR Cartwright","year":"2012","unstructured":"Cartwright BR, Goodman JM (2012) Seipin: from human disease to molecular mechanism. J Lipid Res 53:1042\u20131055","journal-title":"J Lipid Res"},{"key":"2926_CR9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tem.2011.02.004","volume":"22","author":"W Fei","year":"2011","unstructured":"Fei W, Du X, Yang H (2011) Seipin, adipogenesis and lipid droplets. Trends Endocrinol Metab 22:204\u2013210","journal-title":"Trends Endocrinol Metab"},{"key":"2926_CR10","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1194\/jlr.M017566","volume":"52","author":"W Fei","year":"2011","unstructured":"Fei W, Li H, Shui G et al (2011) Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis. J Lipid Res 52:2136\u20132147","journal-title":"J Lipid Res"},{"key":"2926_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200711136","volume":"180","author":"W Fei","year":"2008","unstructured":"Fei W, Shui G, Gaeta B et al (2008) Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. J Cell Biol 180:473\u2013482","journal-title":"J Cell Biol"},{"key":"2926_CR12","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1242\/jcs.091454","volume":"124","author":"H Wolinski","year":"2011","unstructured":"Wolinski H, Kolb D, Hermann S, Koning RI, Kohlwein SD (2011) A role for seipin in lipid droplet dynamics and inheritance in yeast. J Cell Sci 124:3894\u20133904","journal-title":"J Cell Sci"},{"key":"2926_CR13","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","volume":"57","author":"VA Payne","year":"2008","unstructured":"Payne VA, Grimsey N, Tuthill A et al (2008) The human lipodystrophy gene BSCL2\/seipin may be essential for normal adipocyte differentiation. Diabetes 57:2055\u20132060","journal-title":"Diabetes"},{"key":"2926_CR14","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/en.2009-0236","volume":"150","author":"W Chen","year":"2009","unstructured":"Chen W, Yechoor VK, Chang BH, Li MV, March KL, Chan L (2009) The human lipodystrophy gene product BSCL2\/seipin plays a key role in adipocyte differentiation. Endocrinology 150:4552\u20134561","journal-title":"Endocrinology"},{"key":"2926_CR15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/MCB.06465-11","volume":"32","author":"W Chen","year":"2012","unstructured":"Chen W, Chang B, Saha P et al (2012) Berardinelli-Seip congenital lipodystrophy 2\/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation. Mol Cell Biol 32:1099\u20131111","journal-title":"Mol Cell Biol"},{"key":"2926_CR16","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/hmg\/ddr205","volume":"20","author":"X Cui","year":"2011","unstructured":"Cui X, Wang Y, Tang Y et al (2011) Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet 20:3022\u20133030","journal-title":"Hum Mol Genet"},{"key":"2926_CR17","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1210\/en.2006-0098","volume":"147","author":"G Lambert","year":"2006","unstructured":"Lambert G, Jarnoux AL, Pineau T et al (2006) Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. Endocrinology 147:4985\u20134995","journal-title":"Endocrinology"},{"key":"2926_CR18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 31:1116\u20131128","journal-title":"NeuroImage"},{"key":"2926_CR19","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M510258200","volume":"281","author":"B Cariou","year":"2006","unstructured":"Cariou B, van Harmelen K, Duran-Sandoval D et al (2006) The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281:11039\u201311049","journal-title":"J Biol Chem"},{"key":"2926_CR20","doi-asserted-by":"crossref","first-page":"36759","DOI":"10.1074\/jbc.M110.166231","volume":"285","author":"M Abdelkarim","year":"2010","unstructured":"Abdelkarim M, Caron S, Duhem C et al (2010) The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt\/beta-catenin pathways. J Biol Chem 285:36759\u201336767","journal-title":"J Biol Chem"},{"key":"2926_CR21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biochi.2009.01.011","volume":"91","author":"E Boutet","year":"2009","unstructured":"Boutet E, El Mourabit H, Prot M et al (2009) Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy. Biochimie 91:796\u2013803","journal-title":"Biochimie"},{"key":"2926_CR22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1101\/gad.14.11.1293","volume":"14","author":"ED Rosen","year":"2000","unstructured":"Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293\u20131307","journal-title":"Genes Dev"},{"key":"2926_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","volume":"23","author":"B Cariou","year":"2012","unstructured":"Cariou B, Charbonnel B, Staels B (2012) Thiazolidinediones and PPARgamma agonists: time for a reassessment. Trends Endocrinol Metab 23:205\u2013215","journal-title":"Trends Endocrinol Metab"},{"key":"2926_CR24","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1152\/ajpendo.00367.2009","volume":"298","author":"H Tao","year":"2010","unstructured":"Tao H, Aakula S, Abumrad NN, Hajri T (2010) Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Am J Physiol Endocrinol Metab 298:E68\u2013E79","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2926_CR25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-5491.2010.03052.x","volume":"27","author":"B Victoria","year":"2010","unstructured":"Victoria B, Cabezas-Agricola JM, Gonzalez-Mendez B et al (2010) Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy. Diabet Med 27:1178\u20131187","journal-title":"Diabet Med"},{"key":"2926_CR26","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI11245","volume":"106","author":"L Chao","year":"2000","unstructured":"Chao L, Marcus-Samuels B, Mason MM et al (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106:1221\u20131228","journal-title":"J Clin Invest"},{"key":"2926_CR27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","volume":"92","author":"S Ishibashi","year":"1993","unstructured":"Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883\u2013893","journal-title":"J Clin Invest"},{"key":"2926_CR28","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.274.42.30028","volume":"274","author":"I Shimomura","year":"1999","unstructured":"Shimomura I, Bashmakov Y, Horton JD (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028\u201330032","journal-title":"J Biol Chem"},{"key":"2926_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","volume":"6","author":"I Shimomura","year":"2000","unstructured":"Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice. Mol Cell 6:77\u201386","journal-title":"Mol Cell"},{"key":"2926_CR30","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","volume":"278","author":"O Gavrilova","year":"2003","unstructured":"Gavrilova O, Haluzik M, Matsusue K et al (2003) Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278:34268\u201334276","journal-title":"J Biol Chem"},{"key":"2926_CR31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","volume":"48","author":"RA Hegele","year":"2007","unstructured":"Hegele RA, Joy TR, Al-Attar SA, Rutt BK (2007) Thematic review series: adipocyte biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 48:1433\u20131444","journal-title":"J Lipid Res"},{"key":"2926_CR32","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1210\/jc.2012-1872","volume":"97","author":"D Aotani","year":"2012","unstructured":"Aotani D, Ebihara K, Sawamoto N et al (2012) Functional magnetic resonance imaging analysis of food-related brain activity in patients with lipodystrophy undergoing leptin replacement therapy. J Clin Endocrinol Metab 97:3663\u20133671","journal-title":"J Clin Endocrinol Metab"},{"key":"2926_CR33","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","volume":"54","author":"ED Javor","year":"2005","unstructured":"Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P (2005) Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54:1994\u20132002","journal-title":"Diabetes"},{"key":"2926_CR34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","volume":"92","author":"K Ebihara","year":"2007","unstructured":"Ebihara K, Kusakabe T, Hirata M et al (2007) Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 92:532\u2013541","journal-title":"J Clin Endocrinol Metab"},{"key":"2926_CR35","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2006-3165","volume":"120","author":"J Beltrand","year":"2007","unstructured":"Beltrand J, Beregszaszi M, Chevenne D et al (2007) Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy. Pediatrics 120:e291\u2013e296","journal-title":"Pediatrics"},{"key":"2926_CR36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1530\/EJE-09-1027","volume":"162","author":"J Beltrand","year":"2010","unstructured":"Beltrand J, Lahlou N, Le Charpentier T et al (2010) Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin. Eur J Endocrinol 162:1083\u20131091","journal-title":"Eur J Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-013-2926-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2926-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T05:04:18Z","timestamp":1645074258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-013-2926-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2926"],"URL":"https:\/\/doi.org\/10.1007\/s00125-013-2926-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}